SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson's disease
SGLT2 抑制剂恩格列净以 FUNDC1 依赖的方式缓解实验性帕金森病中的心脏重塑和收缩异常
期刊:Acta Pharmacologica Sinica
影响因子:6.9
doi:10.1038/s41401-023-01144-0
Wei Yu #, Lin Wang #, Wei-Ying Ren #, Hai-Xia Xu, Ne N Wu, Dong-Hui Yu, Russel J Reiter, Wen-Liang Zha, Qing-Dong Guo, Jun Ren5